Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 237 of 237 entries
Sorted by: Best Match Show Resources per page
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020.

Journal of clinical medicine

Capai L, Ayhan N, Masse S, Canarelli J, Priet S, Simeoni MH, Charrel R, Lamballerie X, Falchi A.
PMID: 33167563
J Clin Med. 2020 Nov 05;9(11). doi: 10.3390/jcm9113569.

Our aim was to assess the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection after the lockdown in a sample of the Corsican population. Between 16 April and 15 June 2020, 2312 residual sera were collected from patients...

Cite
Capai L, Ayhan N, Masse S, et al. Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020. J Clin Med. 2020;9(11)doi: 10.3390/jcm9113569.
Capai, L., Ayhan, N., Masse, S., Canarelli, J., Priet, S., Simeoni, M. H., Charrel, R., Lamballerie, X., & Falchi, A. (2020). Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020. Journal of clinical medicine, 9(11), . https://doi.org/10.3390/jcm9113569
Capai, Lisandru, et al. "Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020." Journal of clinical medicine vol. 9,11 (2020). doi: https://doi.org/10.3390/jcm9113569
Capai L, Ayhan N, Masse S, Canarelli J, Priet S, Simeoni MH, Charrel R, Lamballerie X, Falchi A. Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020. J Clin Med. 2020 Nov 05;9(11). doi: 10.3390/jcm9113569. PMID: 33167563; PMCID: PMC7694549.
Copy Download .nbib Format: NLM
Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age.

Cancers

Niedersüß-Beke D, Orlinger M, Falch D, Heiler C, Piringer G, Thaler J, Hilbe W, Petzer A, Rumpold H.
PMID: 33925931
Cancers (Basel). 2021 Apr 26;13(9). doi: 10.3390/cancers13092091.

We aimed to investigate the effectiveness of oncological treatments in metastatic CRC related to comorbidities and age. This retrospective study included 1105 patients from three oncological centers. aaCCI and CCI was available from 577 patients. An aaCCI > 3...

Cite
Niedersüß-Beke D, Orlinger M, Falch D, et al. Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age. Cancers (Basel). 2021;13(9)doi: 10.3390/cancers13092091.
Niedersüß-Beke, D., Orlinger, M., Falch, D., Heiler, C., Piringer, G., Thaler, J., Hilbe, W., Petzer, A., & Rumpold, H. (2021). Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age. Cancers, 13(9), . https://doi.org/10.3390/cancers13092091
Niedersüß-Beke, Dora, et al. "Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age." Cancers vol. 13,9 (2021). doi: https://doi.org/10.3390/cancers13092091
Niedersüß-Beke D, Orlinger M, Falch D, Heiler C, Piringer G, Thaler J, Hilbe W, Petzer A, Rumpold H. Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age. Cancers (Basel). 2021 Apr 26;13(9). doi: 10.3390/cancers13092091. PMID: 33925931; PMCID: PMC8123394.
Copy Download .nbib Format: NLM
Associations between pediatric intensive care procedures and urinary free-BPA levels.

Environmental science and pollution research international

Ayar G, Yalçın SS, Yırün A, Emeksiz S, Balcı A, Erkekoğlu P.
PMID: 34595711
Environ Sci Pollut Res Int. 2021 Sep 30; doi: 10.1007/s11356-021-16677-2. Epub 2021 Sep 30.

BACKGROUND: Bisphenol A (BPA) is found in many medical materials used in the paediatric intensive care unit (PICU). Our aim was to evaluate how the urinary free-BPA(fBPA) and total-BPA(tBPA) levels were associated with the use of medical devices in...

Cite
Ayar G, Yalçın SS, Yırün A, et al. Associations between pediatric intensive care procedures and urinary free-BPA levels. Environ Sci Pollut Res Int. 2021;doi: 10.1007/s11356-021-16677-2.
Ayar, G., Yalçın, S. S., Yırün, A., Emeksiz, S., Balcı, A., & Erkekoğlu, P. (2021). Associations between pediatric intensive care procedures and urinary free-BPA levels. Environmental science and pollution research international, . https://doi.org/10.1007/s11356-021-16677-2
Ayar, Ganime, et al. "Associations between pediatric intensive care procedures and urinary free-BPA levels." Environmental science and pollution research international vol. (2021). doi: https://doi.org/10.1007/s11356-021-16677-2
Ayar G, Yalçın SS, Yırün A, Emeksiz S, Balcı A, Erkekoğlu P. Associations between pediatric intensive care procedures and urinary free-BPA levels. Environ Sci Pollut Res Int. 2021 Sep 30; doi: 10.1007/s11356-021-16677-2. Epub 2021 Sep 30. PMID: 34595711.
Copy Download .nbib Format: NLM
Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.

mBio

Gálvez C, Grau-Expósito J, Urrea V, Clotet B, Falcó V, Buzón MJ, Martinez-Picado J.
PMID: 34844430
mBio. 2021 Dec 21;12(6):e0307821. doi: 10.1128/mBio.03078-21. Epub 2021 Nov 30.

Knowing the mechanisms that govern the persistence of infected CD4

Cite
Gálvez C, Grau-Expósito J, Urrea V, et al. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy. mBio. 2021;12(6):e0307821doi: 10.1128/mBio.03078-21.
Gálvez, C., Grau-Expósito, J., Urrea, V., Clotet, B., Falcó, V., Buzón, M. J., & Martinez-Picado, J. (2021). Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy. mBio, 12(6), e0307821. https://doi.org/10.1128/mBio.03078-21
Gálvez, Cristina, et al. "Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy." mBio vol. 12,6 (2021): e0307821. doi: https://doi.org/10.1128/mBio.03078-21
Gálvez C, Grau-Expósito J, Urrea V, Clotet B, Falcó V, Buzón MJ, Martinez-Picado J. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy. mBio. 2021 Dec 21;12(6):e0307821. doi: 10.1128/mBio.03078-21. Epub 2021 Nov 30. PMID: 34844430; PMCID: PMC8630536.
Copy Download .nbib Format: NLM
Experimental and CFD evaluation of ozone efficacy against coronavirus and enteric virus contamination on public transport surfaces.

Journal of environmental chemical engineering

Falcó I, Randazzo W, Sánchez G, Vilarroig J, Climent J, Chiva S, Chica A, Navarro-Laboulais J.
PMID: 34422551
J Environ Chem Eng. 2021 Oct;9(5):106217. doi: 10.1016/j.jece.2021.106217. Epub 2021 Aug 17.

The limited information about the routes of the transmission of SARS-CoV-2 within the ongoing pandemic scenario mobilized the administration, industry and academy to develop sanitation and disinfection systems for public and private spaces. Ozone has been proposed as an...

Cite
Falcó I, Randazzo W, Sánchez G, et al. Experimental and CFD evaluation of ozone efficacy against coronavirus and enteric virus contamination on public transport surfaces. J Environ Chem Eng. 2021;9(5):106217doi: 10.1016/j.jece.2021.106217.
Falcó, I., Randazzo, W., Sánchez, G., Vilarroig, J., Climent, J., Chiva, S., Chica, A., & Navarro-Laboulais, J. (2021). Experimental and CFD evaluation of ozone efficacy against coronavirus and enteric virus contamination on public transport surfaces. Journal of environmental chemical engineering, 9(5), 106217. https://doi.org/10.1016/j.jece.2021.106217
Falcó, Irene, et al. "Experimental and CFD evaluation of ozone efficacy against coronavirus and enteric virus contamination on public transport surfaces." Journal of environmental chemical engineering vol. 9,5 (2021): 106217. doi: https://doi.org/10.1016/j.jece.2021.106217
Falcó I, Randazzo W, Sánchez G, Vilarroig J, Climent J, Chiva S, Chica A, Navarro-Laboulais J. Experimental and CFD evaluation of ozone efficacy against coronavirus and enteric virus contamination on public transport surfaces. J Environ Chem Eng. 2021 Oct;9(5):106217. doi: 10.1016/j.jece.2021.106217. Epub 2021 Aug 17. PMID: 34422551; PMCID: PMC8367738.
Copy Download .nbib Format: NLM
Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer.

Diagnostics (Basel, Switzerland)

Holm J, Ahangarani Farahani Z, Gerke O, Baun C, Falch K, Grubbe Hildebrandt M.
PMID: 33260766
Diagnostics (Basel). 2020 Nov 28;10(12). doi: 10.3390/diagnostics10121021.

The purpose was to investigate the interrater agreement of FDG-PET/CT and bone scintigraphy for diagnosing bone recurrence in breast cancer patients. A total of 100 women with suspected recurrence of breast cancer underwent planar whole-body bone scintigraphy with [99mTc]DPD...

Cite
Holm J, Ahangarani Farahani Z, Gerke O, et al. Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer. Diagnostics (Basel). 2020;10(12)doi: 10.3390/diagnostics10121021.
Holm, J., Ahangarani Farahani, Z., Gerke, O., Baun, C., Falch, K., & Grubbe Hildebrandt, M. (2020). Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer. Diagnostics (Basel, Switzerland), 10(12), . https://doi.org/10.3390/diagnostics10121021
Holm, Jorun, et al. "Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer." Diagnostics (Basel, Switzerland) vol. 10,12 (2020). doi: https://doi.org/10.3390/diagnostics10121021
Holm J, Ahangarani Farahani Z, Gerke O, Baun C, Falch K, Grubbe Hildebrandt M. Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer. Diagnostics (Basel). 2020 Nov 28;10(12). doi: 10.3390/diagnostics10121021. PMID: 33260766; PMCID: PMC7760596.
Copy Download .nbib Format: NLM
Naturally Extracted Hydrophobic Solvent and Self-Assembly in Interfacial Polymerization.

ACS applied materials & interfaces

Falca G, Musteata VE, Chisca S, Hedhili MN, Ong C, Nunes SP.
PMID: 34510885
ACS Appl Mater Interfaces. 2021 Sep 22;13(37):44824-44832. doi: 10.1021/acsami.1c07584. Epub 2021 Sep 12.

Pharmaceutical, chemical, and food industries are actively implementing membrane nanofiltration modules in their processes to separate valuable products and recover solvents. Interfacial polymerization (IP) is the most widely used method to produce thin-film composite membranes for nanofiltration and reverse...

Cite
Falca G, Musteata VE, Chisca S, et al. Naturally Extracted Hydrophobic Solvent and Self-Assembly in Interfacial Polymerization. ACS Appl Mater Interfaces. 2021;13(37):44824-44832doi: 10.1021/acsami.1c07584.
Falca, G., Musteata, V. E., Chisca, S., Hedhili, M. N., Ong, C., & Nunes, S. P. (2021). Naturally Extracted Hydrophobic Solvent and Self-Assembly in Interfacial Polymerization. ACS applied materials & interfaces, 13(37), 44824-44832. https://doi.org/10.1021/acsami.1c07584
Falca, Gheorghe, et al. "Naturally Extracted Hydrophobic Solvent and Self-Assembly in Interfacial Polymerization." ACS applied materials & interfaces vol. 13,37 (2021): 44824-44832. doi: https://doi.org/10.1021/acsami.1c07584
Falca G, Musteata VE, Chisca S, Hedhili MN, Ong C, Nunes SP. Naturally Extracted Hydrophobic Solvent and Self-Assembly in Interfacial Polymerization. ACS Appl Mater Interfaces. 2021 Sep 22;13(37):44824-44832. doi: 10.1021/acsami.1c07584. Epub 2021 Sep 12. PMID: 34510885.
Copy Download .nbib Format: NLM
Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol.

Pathogens (Basel, Switzerland)

Pouquet M, Decarreaux D, Prévot-Monsacré P, Hervé C, Werner A, Grosgogeat B, Blanché H, Rabiega P, Laupie J, Kochert F, Abraham N, Sebaoun JM, de Lamballerie X, Charrel R, Souty C, Camara I, Pergeline J, Noël H, Guerrisi C, Werf SV, Carrat F, Hanslik T, Blanchon T, Falchi A.
PMID: 34358061
Pathogens. 2021 Jul 20;10(7). doi: 10.3390/pathogens10070911.

BACKGROUND: The protocol study will focus on the seroprevalence of IgG antibodies to SARS-CoV-2 achieved by vaccination and/or natural protection as well as the history, symptoms, and risk factors for SARS-CoV-2 in four primary health-care workers (PHCWs) and their...

Cite
Pouquet M, Decarreaux D, Prévot-Monsacré P, et al. Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol. Pathogens. 2021;10(7)doi: 10.3390/pathogens10070911.
Pouquet, M., Decarreaux, D., Prévot-Monsacré, P., Hervé, C., Werner, A., Grosgogeat, B., Blanché, H., Rabiega, P., Laupie, J., Kochert, F., Abraham, N., Sebaoun, J. M., de Lamballerie, X., Charrel, R., Souty, C., Camara, I., Pergeline, J., Noël, H., Guerrisi, C., Werf, S. V., Carrat, F., Hanslik, T., Blanchon, T., & Falchi, A. (2021). Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol. Pathogens (Basel, Switzerland), 10(7), . https://doi.org/10.3390/pathogens10070911
Pouquet, Marie, et al. "Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol." Pathogens (Basel, Switzerland) vol. 10,7 (2021). doi: https://doi.org/10.3390/pathogens10070911
Pouquet M, Decarreaux D, Prévot-Monsacré P, Hervé C, Werner A, Grosgogeat B, Blanché H, Rabiega P, Laupie J, Kochert F, Abraham N, Sebaoun JM, de Lamballerie X, Charrel R, Souty C, Camara I, Pergeline J, Noël H, Guerrisi C, Werf SV, Carrat F, Hanslik T, Blanchon T, Falchi A. Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol. Pathogens. 2021 Jul 20;10(7). doi: 10.3390/pathogens10070911. PMID: 34358061; PMCID: PMC8308883.
Copy Download .nbib Format: NLM
Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery.

Journal of the National Comprehensive Cancer Network : JNCCN

Kircher S, Braccio N, Gallagher K, Carlos R, Wagner L, Smith ML, Balch A, Benson AB.
PMID: 34902826
J Natl Compr Canc Netw. 2021 Dec;19(12):1470-1474. doi: 10.6004/jnccn.2021.7111.

No abstract available.

Cite
Kircher S, Braccio N, Gallagher K, et al. Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery. J Natl Compr Canc Netw. 2021;19(12):1470-1474doi: 10.6004/jnccn.2021.7111.
Kircher, S., Braccio, N., Gallagher, K., Carlos, R., Wagner, L., Smith, M. L., Balch, A., & Benson, A. B. (2021). Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery. Journal of the National Comprehensive Cancer Network : JNCCN, 19(12), 1470-1474. https://doi.org/10.6004/jnccn.2021.7111
Kircher, Sheetal, et al. "Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery." Journal of the National Comprehensive Cancer Network : JNCCN vol. 19,12 (2021): 1470-1474. doi: https://doi.org/10.6004/jnccn.2021.7111
Kircher S, Braccio N, Gallagher K, Carlos R, Wagner L, Smith ML, Balch A, Benson AB. Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery. J Natl Compr Canc Netw. 2021 Dec;19(12):1470-1474. doi: 10.6004/jnccn.2021.7111. PMID: 34902826.
Copy Download .nbib Format: NLM
Showing 229 to 237 of 237 entries